High-Dose Deferoxamine in Intracerebral Hemorrhage (HI-DEF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01662895
Recruitment Status : Suspended (By DSMB due to increased incidence of ARDS. See modified protocol [NCT02175225)
First Posted : August 13, 2012
Last Update Posted : January 9, 2018
Medical University of South Carolina
National Institute of Neurological Disorders and Stroke (NINDS)
Massachusetts General Hospital
Tufts Medical Center
University of Massachusetts, Worcester
University of Pennsylvania
Johns Hopkins University
University of Maryland
University of Virginia
Duke University
University of North Carolina
University of Florida
The Cleveland Clinic
Henry Ford Hospital
Ohio State University
St. Joseph's Hospital and Medical Center, Phoenix
University of California, San Francisco
Oregon Health and Science University
Yale New Haven Hospital
University of Iowa
Hartford Hospital
The University of Texas Health Science Center, Houston
Rhode Island Hospital
Stanford University
University of Washington
University of Calgary
Hopital de l'Enfant-Jesus
University of Alberta
Dalhousie University
Information provided by (Responsible Party):
Magdy Selim, Beth Israel Deaconess Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018
Publications automatically indexed to this study by Identifier (NCT Number):